Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14ARF tumor suppressor

被引:319
作者
Dimri, GP [1 ]
Itahana, K [1 ]
Acosta, M [1 ]
Campisi, J [1 ]
机构
[1] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Cell & Mol Biol, Berkeley, CA 94720 USA
关键词
D O I
10.1128/MCB.20.1.273-285.2000
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Normal cells do not divide indefinitely due to a process known as replicative senescence. Human cells arrest growth with a senescent phenotype when they acquire one or more critically short telomeres as a consequence of cell division. Recent evidence suggests that certain: types:of DNA damage, chromatin remodeling, and oncogenic forms of Ras or Raf can also elicit a senescence response. We show here that E2F1, a multifunctional transcription factor that binds the retinoblastoma (pRb) tumor suppressor and that can either promote or suppress tumorigenesis, induces a senescent phenotype when overexpressed in normal human fibroblasts. Normal human cells stably arrested proliferation and expressed several markers of replicative senescence in response to E2F1. This activity of E2F1 was independent of its pRb binding activity but dependent on its ability to stimulate gene expression. The E2F1 target gene critical for the senescence response appeared to be the p14(ARF) tumor suppressor. Replicatively senescent human fibroblasts overexpressed p14(ARF), and ectopic expression of p14(ARF) in presenescent cells induced a phenotype similar to that induced by E2F1. Consistent with a critical role for p14(ARF), cells with compromised p53 function were immune to senescence induction by E2F1, as were cells deficient in p14(ARF). Our findings support the idea that the senescence response is a critical tumor-suppressive mechanism, provide an explanation for the apparently paradoxical roles of E2F1 in oncogenesis, and identify p14(ARF) as a potentially important mediator of the senescent phenotype.
引用
收藏
页码:273 / 285
页数:13
相关论文
共 78 条
  • [1] INVESTIGATION OF THE ROLE OF G(1)/S CELL-CYCLE MEDIATORS IN CELLULAR SENESCENCE
    AFSHARI, CA
    VOJTA, PJ
    ANNAB, LA
    FUTREAL, PA
    WILLARD, TB
    BARRETT, JC
    [J]. EXPERIMENTAL CELL RESEARCH, 1993, 209 (02) : 231 - 237
  • [2] Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts
    Alcorta, DA
    Xiong, Y
    Phelps, D
    Hannon, G
    Beach, D
    Barrett, JC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) : 13742 - 13747
  • [3] INCREASED ACTIVITY OF P53 IN SENESCING FIBROBLASTS
    ATADJA, P
    WONG, H
    GARKAVTSEV, I
    VEILLETTE, C
    RIABOWOL, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (18) : 8348 - 8352
  • [4] p14ARF links the tumour suppressors RB and p53
    Bates, S
    Phillips, AC
    Clark, PA
    Stott, F
    Peters, G
    Ludwig, RL
    Vousden, KH
    [J]. NATURE, 1998, 395 (6698) : 124 - 125
  • [5] Blattner C, 1999, MOL CELL BIOL, V19, P3704
  • [6] Extension of life-span by introduction of telomerase into normal human cells
    Bodnar, AG
    Ouellette, M
    Frolkis, M
    Holt, SE
    Chiu, CP
    Morin, GB
    Harley, CB
    Shay, JW
    Lichtsteiner, S
    Wright, WE
    [J]. SCIENCE, 1998, 279 (5349) : 349 - 352
  • [7] Aging and cancer: The double-edged sword of replicative senescence
    Campisi, J
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (04) : 482 - 488
  • [8] Replicative senescence: An old lives' tale?
    Campisi, J
    [J]. CELL, 1996, 84 (04) : 497 - 500
  • [9] Campisi Judith, 1996, P121
  • [10] Molecular analysis of H2O2-induced senescent-like growth arrest in normal human fibroblasts:: p53 and Rb control G1 arrest but not cell replication
    Chen, QM
    Bartholomew, JC
    Campisi, J
    Acosta, M
    Reagan, JD
    Ames, BN
    [J]. BIOCHEMICAL JOURNAL, 1998, 332 : 43 - 50